ARMP

Armata Pharmctcl

• TipRanks·05/14 10:44

  H.C. Wainwright Reaffirms Their Buy Rating on Armata Pharmaceuticals (ARMP)

• TipRanks·05/13 22:17

  Armata Secures New Loan Amid Wider Quarterly Loss

• TipRanks·05/13 21:41

  Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year

• Seeking Alpha·05/13 20:53

  Armata Pharmaceuticals GAAP EPS of -$3.16 misses by $2.78, revenue of $0.79M

• Benzinga·05/13 20:42

  Armata Pharmaceuticals Q1 EPS $(3.16) Misses $(0.38) Estimate, Sales $789.000K Up From $491.000K YoY

• Dow Jones·05/13 20:42

  *Armata Pharma Entered Into Secured Credit Agreement With Innoviva for $25 M Maturing in 2029 >ARMP

• Dow Jones·05/13 20:41

  *Armata Pharmaceuticals 1Q Loss $115.3M >ARMP

• Dow Jones·05/13 20:30

  Press Release: Armata Pharmaceuticals Announces -3-

• PR Newswire·05/13 20:30

  Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update

• Dow Jones·05/13 20:30

  *Armata Pharmaceuticals 1Q Loss/Shr $3.16 >ARMP

• TipRanks·05/07 19:50

  Analysts Offer Insights on Healthcare Companies: Armata Pharmaceuticals (ARMP), Palvella Therapeutics (PVLA) and MBX Biosciences, Inc. (MBX)

• TipRanks·05/07 13:17

  Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02

• TipRanks·05/07 11:57

  Armata Gains FDA Fast Track for AP-SA02 Therapy

• Benzinga·05/07 11:40

  Armata Pharmaceuticals Granted FDA's Fast Track Designation For AP-SA02 To Treat Bacterial Infections

• PR Newswire·05/07 11:00

  Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02